FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single pat...

  • U.S. Food and Drug Administration
  • June 20, 2012
  • ID: D-1382-2012

Drug Enforcement Report Details

Recall NumberD-1382-2012
Recalling FirmHospira, Inc.
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternNationwide.
StatusTerminated
Product Description

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

Reason for Recall

Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

Code Information

Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.